Creative Financial Designs’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$594 Hold
80
﹤0.01% 1979
2025
Q4
$941 Hold
80
﹤0.01% 1800
2025
Q3
$618 Hold
80
﹤0.01% 1900
2025
Q2
$585 Hold
80
﹤0.01% 1881
2025
Q1
$759 Hold
80
﹤0.01% 1838
2024
Q4
$1.32K Hold
80
﹤0.01% 1661
2024
Q3
$1.18K Hold
80
﹤0.01% 1569
2024
Q2
$1.11K Hold
80
﹤0.01% 1535
2024
Q1
$1.26K Hold
80
﹤0.01% 1530
2023
Q4
$1.29K Hold
80
﹤0.01% 1481
2023
Q3
$984 Hold
80
﹤0.01% 1399
2023
Q2
$1.29K Hold
80
﹤0.01% 1355
2023
Q1
$1.39K Hold
80
﹤0.01% 1284
2022
Q4
$739 Hold
80
﹤0.01% 1224
2022
Q3
$1K Hold
80
﹤0.01% 1244
2022
Q2
$1K Hold
80
﹤0.01% 1200
2022
Q1
$1K Hold
80
﹤0.01% 1218
2021
Q4
$3K Hold
80
﹤0.01% 1090
2021
Q3
$4K Hold
80
﹤0.01% 1201
2021
Q2
$4K Hold
80
﹤0.01% 1225
2021
Q1
$4K Hold
80
﹤0.01% 1111
2020
Q4
$4K Hold
80
﹤0.01% 1035
2020
Q3
$3K Hold
80
﹤0.01% 1038
2020
Q2
$2K Buy
+80
New +$2.22K ﹤0.01% 1039

Other funds holding NEO

Creative Financial Designs's NEO Position: Q1 2026 in Review

Creative Financial Designs held its NeoGenomics (NEO) position steady in Q1 2026 at 80 shares worth $594. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

Creative Financial Designs first reported a position in NEO in Q2 2020 and has held it in 24 quarters since. The position peaked at $4K in Q3 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Creative Financial Designs held 80 shares of NeoGenomics worth $594 as of Q1 2026.
  • Creative Financial Designs left its NeoGenomics share count unchanged in Q1 2026.
  • NeoGenomics made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1979 holding.
  • Creative Financial Designs first reported a position in NeoGenomics in Q2 2020 and has held it in 24 quarters since.
  • Creative Financial Designs's NeoGenomics position peaked at $4K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.